Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment |
| |
Authors: | Andrew H Talal MD MPH Rositsa B Dimova Randy Seewald Raymond H PetersonMarija Zeremski PhD David C Perlman Don C Des Jarlais |
| |
Institution: | 1. Center for the Study of Hepatitis C and Division of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, NY;2. Department of Medicine, Beth Israel Medical Center, New York, NY;3. Baron de Rothschild Chemical Dependency Research Institute, Beth Israel Medical Center, New York, NY;4. Center for Drug Use and HIV Research, New York, NY |
| |
Abstract: | We used a 25-item, self-administered questionnaire to assess staff's perceived barriers and willingness to engage in onsite treatment of hepatitis C virus (HCV) at the Beth Israel Medical Center methadone maintenance treatment program (MMTP) at its Harlem sites. Of 80 participants, 50% were counselors and 24% were directly involved in referral or HCV testing. Although 92% of the MMTP staff indicated that they discuss HCV evaluation and treatment with patients at least annually, 70% believed that less than 25% of patients accept referral for HCV treatment and attend their initial appointment. Most staff (66%) supported onsite HCV evaluation and treatment, although support was higher among those with a bachelor's degree or higher (p = 0.046). Lack of infrastructure was perceived as the greatest obstacle to onsite treatment. Educational interventions and skill building for staff to confidently engage and support MMTP patients in HCV treatment may be necessary prerequisites for onsite HCV management in MMTPs. |
| |
Keywords: | Drug treatment Hepatitis C virus treatment Interferon Methadone maintenance Opiate substitution therapy |
本文献已被 ScienceDirect 等数据库收录! |
|